Of the 15 women.

– The average age that the women thought they would use their frozen oocytes was 43, an age at which women women there are significant difficulties in achieving a spontaneous conception But if they found a suitable partner, most They would prefer They would prefer to try to get pregnant spontaneously, rather than perform IVF with fresh material or in the last instance, use their frozen embryos, said Dr. Nekkebroeck.. Of the 15 women, 53 felt that the financial cost in in treatment, 7 percent believed that the use of hormones was a deterrent. However, all of them accepted that they be subjected to a treatment while they still need healthy and fertile, and they were ready to repeat the treatment at least twice.

But in group B were the financial stability followed of a stable relationship and then for professional reasons. We think that this is the first time that young women have been studied attitudes to egg freezing that way. .

‘There is a lot of misinformation about the age at which the women could start their families, from society of the treatment and the number of eggs that must be retrieved and frozen to provide a realistic prospect for the future indicate success. Women think make this intervention to undergo detailing and have counseling to both the benefits and limitations of oocyte freezing compared with other options. Them them, the decision to remove the right for their circumstances, ‘she said.. In the second study, Julie Nekkebroeck*, a senior psychologist at the Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium, found that a group of well educated and financially secure women advertised with an average age of just over 38 years have frozen their eggs, they have not the right partner with whom the children have found.And 5th Rare – Cell testing designed to make early progression to cervical Identify.

Ikonisys, a leader in next-generation, cell-based diagnostic solution, announced today the availability of its clinically validated, new type of cervical test oncoFIS the cervical. Associated with its proprietary Cell OpticFilm platform, a robotic microscopy systems oncoFISH cervical offers the physician, while still adhered current guidelines. With estimation of the risk the progress of the relatively low grade dysplasia, cancers of the cervix oncoFISH cervical offered as an laboratory developed test of licensed CAP – an accredited Ikonisys Clinical Laboratory Dental be.